Due to its elevated expression and requirement for CSC induction and tumorigenesis, we suggest that podoplanin may be used as a predictive biomarker for cancer risk assessment and for safer by design screening of CNTs and related nanomaterials. This evidence concerns the gene PDPN and cancer.